Overview
Research | Process | Pre-clinical | Phase 1 | Phase 2 | Phase 3 | |||
---|---|---|---|---|---|---|---|---|
ALT-P1 | Long-acting Human Growth Hormone | |||||||
Domestic Phase II in Progress / Preparation of global Phase II | ||||||||
ALT-Q2 | Long-acting Factor Vlla | |||||||
Process Development in Progress | ||||||||
ALT-P7 | Breast/Gastric Cancer ADC | |||||||
Preparation of Phase II Clinical Trial | ||||||||
ALT-Q5 | Ovarian Cancer ADC | |||||||
Process Development in Progress | ||||||||
ALT-L9 | Eylea Biosimilar | |||||||
First-in human Domestic Phase I Clinical Trial in Progress | ||||||||
ALT-L2 | Herceptin Biosimilar | |||||||
Preparation of Global Phase III Clinical Trial | ||||||||
ALT-LS2 | Herceptin SC Biosimilar | |||||||
Process Development in Progress |